(Q44985602)

8 December 2017

User-only design to assess drug effectiveness in clinical practice: application to bisphosphonates and secondary prevention of fractures (English)

1 reference

8 December 2017

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Gianluca Della Vedova

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Dario Gregori

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Mauro Di Bari

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Giovanni Corrao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Arianna Ghirardi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Giulia Segafredo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Francesco Lapi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Francesco Cipriani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Achille Caputi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Alberto Vaccheri

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Rosaria Gesuita

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Annarita Vestri

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Tommaso Staniscia

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Giampiero Mazzaglia

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

BEST investigators

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

9 June 2014

1 reference

Pharmacoepidemiology and Drug Safety

8 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

859-867

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24911392%20AND%20SRC:MED&resulttype=core&format=json

Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results

7 June 2020

cites work

1 reference

Observation and experiment with the efficacy of drugs: a warning example from a cohort of nonsteroidal anti-inflammatory and ulcer-healing drug users

21 January 2018

1 reference

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples

21 January 2018

1 reference

Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures.

21 January 2018

1 reference

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

21 January 2018

1 reference

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial

21 January 2018

1 reference

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

21 January 2018

1 reference

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

21 January 2018

1 reference

Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group

21 January 2018

1 reference

Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis

21 January 2018

1 reference

Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013.

21 January 2018

1 reference

Developments in post-marketing comparative effectiveness research

21 January 2018

1 reference

Low Frequency of Treatment of Osteoporosis Among Postmenopausal Women Following a Fracture

21 January 2018

1 reference

Undertreatment with anti-osteoporotic drugs after hospitalization for fracture

21 January 2018

1 reference

A systematic review of persistence and compliance with bisphosphonates for osteoporosis

21 January 2018

1 reference

The central role of the propensity score in observational studies for causal effects

21 January 2018

1 reference

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

21 January 2018

1 reference

https://api.fatcat.wiki/v0/release/h5272wh5jjfb7fq3zurgclfkii

21 January 2018

Identifiers

1 reference

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_h5272wh5jjfb7fq3zurgclfkii

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h5272wh5jjfb7fq3zurgclfkii

mapped directly with Wikidata item

30 July 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/h5272wh5jjfb7fq3zurgclfkii